Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2003 | 12-2002 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 10,073 | N/A |
| Marketable Securities | 1,504 | N/A |
| TOTAL | $11,743 | $N/A |
| Non-Current Assets | ||
| PPE Net | 1 | N/A |
| Other Non-Current Assets | 38 | 0 |
| TOTAL | $38 | $N/A |
| Total Assets | $11,781 | $N/A |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 322 | 0 |
| Accrued Expenses | 334 | N/A |
| TOTAL | $1,014 | $N/A |
| Non-Current Liabilities | ||
| aiOther Non-Current Liabilities | 524 | 0 |
| TOTAL | $524 | $N/A |
| Total Liabilities | $1,538 | $N/A |
| Shareholders' Equity | ||
| Common Shares | 9 | N/A |
| Retained earnings | -37,937 | N/A |
| Other shareholders' equity | 39,190 | 0 |
| TOTAL | $10,243 | $N/A |
| Total Liabilities And Equity | $11,781 | $0 |